A microinjection platform enables assessment of multiple cancer drugs directly in tumors and predicts systemic response to the drugs, a new study found. Researchers at Fred Hutchinson Cancer Research Center and Presage Biosciences found that a newly developed technology for simultaneously comparing response to multiple cancer drugs or combinations while …